219 related articles for article (PubMed ID: 30340537)
1. Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis.
Yang Y; Qiu S; Deng L; Tang X; Li X; Wei Q; Fu P
BMC Nephrol; 2018 Oct; 19(1):269. PubMed ID: 30340537
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials.
Yang Y; Qiu S; Tang X; Li XR; Deng LH; Wei Q; Fu P
Chin Med J (Engl); 2018 Apr; 131(7):818-828. PubMed ID: 29578126
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ
Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.
Kan SL; Ning GZ; Chen LX; Zhou Y; Sun JC; Feng SQ
Medicine (Baltimore); 2016 Feb; 95(5):e2679. PubMed ID: 26844505
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis.
Toth-Manikowski SM; Francis JM; Gautam A; Gordon CE
Clin Transplant; 2016 Sep; 30(9):1090-6. PubMed ID: 27327448
[TBL] [Abstract][Full Text] [Related]
6. Interventions for preventing bone disease in kidney transplant recipients.
Palmer SC; McGregor DO; Strippoli GF
Cochrane Database Syst Rev; 2007 Jul; (3):CD005015. PubMed ID: 17636784
[TBL] [Abstract][Full Text] [Related]
7. Interventions for preventing bone disease in kidney transplant recipients.
Palmer S; McGregor DO; Strippoli GF
Cochrane Database Syst Rev; 2005 Apr; (2):CD005015. PubMed ID: 15846740
[TBL] [Abstract][Full Text] [Related]
8. The effect of calcium and vitamin D compounds on bone mineral density in patients undergoing glucocorticoid therapies: a network meta-analysis.
Deng J; Silver Z; Huang E; Zheng E; Kavanagh K; Panicker J
Clin Rheumatol; 2021 Feb; 40(2):725-734. PubMed ID: 32681366
[TBL] [Abstract][Full Text] [Related]
9. Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trials.
Mitterbauer C; Schwarz C; Haas M; Oberbauer R
Nephrol Dial Transplant; 2006 Aug; 21(8):2275-81. PubMed ID: 16574684
[TBL] [Abstract][Full Text] [Related]
10. Effect of bisphosphonates on periprosthetic bone loss after total knee arthroplasty: a meta-analysis of randomized controlled trials.
Shi M; Chen L; Wu H; Wang Y; Wang W; Zhang Y; Yan S
BMC Musculoskelet Disord; 2018 May; 19(1):177. PubMed ID: 29848366
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
Melek J; Sakuraba A
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
[TBL] [Abstract][Full Text] [Related]
12. Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials.
Kasturi KS; Chennareddygari S; Mummadi RR
Transpl Int; 2010 Feb; 23(2):200-7. PubMed ID: 19793074
[TBL] [Abstract][Full Text] [Related]
13. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.
Palmer SC; Strippoli GF; McGregor DO
Am J Kidney Dis; 2005 Apr; 45(4):638-49. PubMed ID: 15806466
[TBL] [Abstract][Full Text] [Related]
14. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.
Wang Z; Han Z; Tao J; Lu P; Liu X; Wang J; Wu B; Huang Z; Yin C; Tan R; Gu M
PLoS One; 2014; 9(9):e108106. PubMed ID: 25265508
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate therapy for osteogenesis imperfecta.
Phillipi CA; Remmington T; Steiner RD
Cochrane Database Syst Rev; 2008 Oct; (4):CD005088. PubMed ID: 18843680
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate therapy for osteogenesis imperfecta.
Dwan K; Phillipi CA; Steiner RD; Basel D
Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
[TBL] [Abstract][Full Text] [Related]
19. Determination of the Combined Effects of Asian Herbal Medicine with Calcium and/or Vitamin D Supplements on Bone Mineral Density in Primary Osteoporosis: A Systematic Review and Meta-Analysis.
Park HJ; Kim MG; Yoo YS; Lee B; Choi YJ; Son CG; Lee EJ
Osteoporos Int; 2024 Jul; 35(7):1-21. PubMed ID: 38472336
[TBL] [Abstract][Full Text] [Related]
20. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
